REPLY
Managing Anticoagulation Safely
Stephan D. Fihn;
Mary McDonnell; and
Donald Martin
1 November 1993 | Volume 119 Issue 9 | Page 957
IN RESPONSE:
We appreciate the thoughtful comments of Dr. Ginier and colleagues. We agree that absence of seasonal variation in the complication rate does not prove that alterations in dietary intake of these foods cannot cause fluctuations in the PTR. However, in geographic locations where these vegetables are available year-round, patients would need to drastically alter their intake for other reasons to induce wide swings in anticoagulation control. We have observed occasional instances of this phenomenon, but our study suggests that other factors are more important causes of variability in the PTR.
We also do not discount the potential for other medications to interfere with anticoagulation control. We were, however, quite encouraged by the results of our study, which indicate that when patients are carefully managed, as they were in our participating clinics, this is uncommon. In large part, this was probably due to the fact that patients in all the clinics were usually instructed to begin no new medications from any source without first checking with the anticoagulation clinic. We do not suppose that these results can be generalized to institutions where patients are being managed without a protocol and by inexperienced practitioners.
Although one study showed that warfarin anticoagulation can be managed safely, warfarin remains a drug with the potential for serious complications. Patients receiving this medication require extensive education and meticulous management. In large institutions, this can usually be accomplished most effectively and efficiently in a dedicated anticoagulation clinic operating within accepted guidelines [1].
1. Hirsh J, Dalen JE, Deykin D, Poller L. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest. 1992; 102(Suppl):312S-26S.
About Letters
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
Include no more than 300 words of text, three authors, and five references
Type with double-spacing
Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.